Login / Signup

Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function.

Carolin SengerA ContiA KlugeD PasemannM KufeldG AckerM LukasA GrünG KalinauskaiteV BudachJ WaiserC Stromberger
Published in: BMC urology (2019)
Robotic SABR is technically feasible for the treatment of RCC in preexisting kidney disease with good local tumor control at about 2 years follow-up. Robotic SABR with motion tracking offers a valid treatment option for patients, who are at increased risk for progression to end-stage renal disease due to partial nephrectomy or ablative techniques.
Keyphrases